Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
about
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavirAntiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.Domestic cat model for predicting human nucleoside analogue pharmacokinetics in blood and seminal plasma.Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily.Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patientsPharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 studySpillover adherence effects of fixed-dose combination HIV therapyPopulation pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.The role of formulation on the pharmacokinetics of antiretroviral drugs.Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection.The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy Subjects.Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis.Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects.
P2860
Q28345258-3E5A67FC-60DF-40E9-92B9-99D0464758DFQ33946645-F4A137D8-52AC-4C6A-9371-C676EAADF263Q33978372-CE4AE666-432E-4456-9DE0-49DDEFA3FB4CQ33982634-819254A3-C7B2-419E-935C-48EB53263CEDQ35005426-C02DA234-7D39-4D04-9E1F-67A6664D727BQ35065817-5E3680B2-2EC1-4856-8E9B-EB75DFEDD2A1Q35806474-664A98DF-B05A-4907-B007-1C2AA5147611Q35808707-5BB57C25-45BC-4B12-96F9-63796986D91CQ37245017-D81270EB-336F-4EFA-8B72-D9D8ABFB7C31Q38216047-FF52F11D-2778-41AB-9BE6-35E64CF359D7Q38620257-A28816EA-396E-453E-BC92-556DE11D6B1DQ38872017-4EAC47CA-487F-4540-93CB-E3D0C85717ECQ39961994-FAEF9B92-8846-4D0D-A081-2B3CB521FAC4Q43554149-BE3D051A-3A21-44F4-AA5A-EA25C1FC8A38Q43580186-81117D13-8A3E-4587-9949-B2BD72C6CD08Q43996453-E22BB4A8-F727-492B-8ADC-D28E191DFAF0Q46233887-AA24DFBF-1CCA-4DF5-B73A-26A3656093C4Q46930423-36A203D9-B281-4DC8-A47E-A8D01330BD5BQ46954371-382216B9-92F8-42A1-8CC2-3EADB0A45BE8
P2860
Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@en
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@nl
type
label
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@en
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@nl
prefLabel
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@en
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@nl
P2093
P2860
P1476
Lamivudine/zidovudine as a com ...... effect of food on absorption.
@en
P2093
Laurent AL
P2860
P304
P356
10.1177/00912709922008209
P577
1999-06-01T00:00:00Z